Insight Molecular Diagnostics (IMDX)

• Market cap: $124M
• 1 day: 4.59%
• 5 days: 6.65%
• 1 month: -23.63%
• 3 months: -32.03%
• 6 months: 30.03%
• Year to date: -39.53%
• 1 year: 36.16%
• 5 years: -95.43%
• 10 years: -95.88%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx.

Employees: 49